arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

AVITA Medical, Inc.

RCEL
$7.76 ▲ +3.04 (+64.41%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
32 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
55
Health
Fair
Neutral
auto_awesome

Analytical Summary

AVITA Medical, Inc. shows mixed fundamentals. However, watch Profit Margin (%) which shows concerning trends. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $237.0M
Dividend Yield
Revenue Growth 4.0%
Op. Margin -45.7%
ROIC 38.0%
FCF / Share $-0.33
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

32-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$19.25M
↑ +4.0%
Net Income Profit after all expenses
$-10.61M
↑ +23.4%
Operating Margin Operating profit as % of sales
-45.7%
↑ +22.6% 4th
FCF / Share Free cash flow per share
$-0.33
↑ +17.6%
Long-Term Debt Long-term obligations
$0.00
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
5
Returns
100
Financial Health
64
Cash Quality
47

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 32 quarters